Literature DB >> 1938791

Treatment of ADHD with fluoxetine: a preliminary trial.

L Barrickman1, R Noyes, S Kuperman, E Schumacher, M Verda.   

Abstract

Nineteen children and adolescents with attention-deficit hyperactivity disorder were treated with fluoxetine hydrochloride. The drug was administered in an open-label fashion for 6 weeks. At completion of the study, nearly 60% were judged to be at least moderately improved. No effects on appetite or weight were observed, and side effects were minimal. These findings suggest that fluoxetine may prove to be an alternative treatment for some attention-deficit hyperactivity disorder patients.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1938791

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN： 0890-8567            Impact factor:   8.829


  16 in total

Review 1.  Non-stimulant treatments for ADHD.

Authors:  J Biederman; T Spencer
Journal:  Eur Child Adolesc Psychiatry       Date:  2000       Impact factor: 4.785

Review 2.  The pharmacological management of childhood anxiety disorders: a review.

Authors:  Shauna P Reinblatt; Mark A Riddle
Journal:  Psychopharmacology (Berl)       Date:  2007-01-05       Impact factor: 4.530

Review 3.  Managing attention deficit/hyperactivity disorder: unmet needs and future directions.

Authors:  C R Steer
Journal:  Arch Dis Child       Date:  2005-02       Impact factor: 3.791

4.  The rare DAT coding variant Val559 perturbs DA neuron function, changes behavior, and alters in vivo responses to psychostimulants.

Authors:  Marc A Mergy; Raajaram Gowrishankar; Paul J Gresch; Stephanie C Gantz; John Williams; Gwynne L Davis; C Austin Wheeler; Gregg D Stanwood; Maureen K Hahn; Randy D Blakely
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-20       Impact factor: 11.205

5.  Altered interregional molecular associations of the serotonin transporter in attention deficit/hyperactivity disorder assessed with PET.

Authors:  Thomas Vanicek; Alexandra Kutzelnigg; Cecile Philippe; Helen L Sigurdardottir; Gregory M James; Andreas Hahn; Georg S Kranz; Anna Höflich; Alexander Kautzky; Tatjana Traub-Weidinger; Marcus Hacker; Wolfgang Wadsak; Markus Mitterhauser; Siegfried Kasper; Rupert Lanzenberger
Journal:  Hum Brain Mapp       Date:  2016-10-22       Impact factor: 5.038

Review 6.  Antidepressant-Induced Activation in Children and Adolescents: Risk, Recognition and Management.

Authors:  Marissa J Luft; Martine Lamy; Melissa P DelBello; Robert K McNamara; Jeffrey R Strawn
Journal:  Curr Probl Pediatr Adolesc Health Care       Date:  2018-01-19

Review 7.  Current drug therapy recommendations for the treatment of attention deficit hyperactivity disorder.

Authors:  M Cyr; C S Brown
Journal:  Drugs       Date:  1998-08       Impact factor: 9.546

Review 8.  Treatment of obsessive-compulsive disorder in children and adolescents. A review of the literature.

Authors:  P H Thomsen
Journal:  Eur Child Adolesc Psychiatry       Date:  1996-06       Impact factor: 4.785

Review 9.  Non-stimulant medications in the treatment of ADHD.

Authors:  Tobias Banaschewski; Veit Roessner; Ralf W Dittmann; Paramala Janardhanan Santosh; Aribert Rothenberger
Journal:  Eur Child Adolesc Psychiatry       Date:  2004       Impact factor: 4.785

10.  Treatment response in depressed adolescents with and without co-morbid attention-deficit/hyperactivity disorder in the Treatment for Adolescents with Depression Study.

Authors:  Christopher J Kratochvil; Diane E May; Susan G Silva; Vishal Madaan; Susan E Puumala; John F Curry; John Walkup; Hayden Kepley; Benedetto Vitiello; John S March
Journal:  J Child Adolesc Psychopharmacol       Date:  2009-10       Impact factor: 2.576
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.